Cargando…
Comparative Analysis and Modeling of the Severity of Steatohepatitis in DDC-Treated Mouse Strains
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease states ranging from mild steatosis characterized by an abnormal retention of lipids within liver cells to steatohepatitis (NASH) showing fat accumulation, inflammation, ballooning and degradation of hepatocytes, an...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210132/ https://www.ncbi.nlm.nih.gov/pubmed/25347188 http://dx.doi.org/10.1371/journal.pone.0111006 |
_version_ | 1782341329176494080 |
---|---|
author | Pandey, Vikash Sultan, Marc Kashofer, Karl Ralser, Meryem Amstislavskiy, Vyacheslav Starmann, Julia Osprian, Ingrid Grimm, Christina Hache, Hendrik Yaspo, Marie-Laure Sültmann, Holger Trauner, Michael Denk, Helmut Zatloukal, Kurt Lehrach, Hans Wierling, Christoph |
author_facet | Pandey, Vikash Sultan, Marc Kashofer, Karl Ralser, Meryem Amstislavskiy, Vyacheslav Starmann, Julia Osprian, Ingrid Grimm, Christina Hache, Hendrik Yaspo, Marie-Laure Sültmann, Holger Trauner, Michael Denk, Helmut Zatloukal, Kurt Lehrach, Hans Wierling, Christoph |
author_sort | Pandey, Vikash |
collection | PubMed |
description | BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease states ranging from mild steatosis characterized by an abnormal retention of lipids within liver cells to steatohepatitis (NASH) showing fat accumulation, inflammation, ballooning and degradation of hepatocytes, and fibrosis. Ultimately, steatohepatitis can result in liver cirrhosis and hepatocellular carcinoma. METHODOLOGY AND RESULTS: In this study we have analyzed three different mouse strains, A/J, C57BL/6J, and PWD/PhJ, that show different degrees of steatohepatitis when administered a 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) containing diet. RNA-Seq gene expression analysis, protein analysis and metabolic profiling were applied to identify differentially expressed genes/proteins and perturbed metabolite levels of mouse liver samples upon DDC-treatment. Pathway analysis revealed alteration of arachidonic acid (AA) and S-adenosylmethionine (SAMe) metabolism upon other pathways. To understand metabolic changes of arachidonic acid metabolism in the light of disease expression profiles a kinetic model of this pathway was developed and optimized according to metabolite levels. Subsequently, the model was used to study in silico effects of potential drug targets for steatohepatitis. CONCLUSIONS: We identified AA/eicosanoid metabolism as highly perturbed in DDC-induced mice using a combination of an experimental and in silico approach. Our analysis of the AA/eicosanoid metabolic pathway suggests that 5-hydroxyeicosatetraenoic acid (5-HETE), 15-hydroxyeicosatetraenoic acid (15-HETE) and prostaglandin D2 (PGD2) are perturbed in DDC mice. We further demonstrate that a dynamic model can be used for qualitative prediction of metabolic changes based on transcriptomics data in a disease-related context. Furthermore, SAMe metabolism was identified as being perturbed due to DDC treatment. Several genes as well as some metabolites of this module show differences between A/J and C57BL/6J on the one hand and PWD/PhJ on the other. |
format | Online Article Text |
id | pubmed-4210132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-42101322014-10-30 Comparative Analysis and Modeling of the Severity of Steatohepatitis in DDC-Treated Mouse Strains Pandey, Vikash Sultan, Marc Kashofer, Karl Ralser, Meryem Amstislavskiy, Vyacheslav Starmann, Julia Osprian, Ingrid Grimm, Christina Hache, Hendrik Yaspo, Marie-Laure Sültmann, Holger Trauner, Michael Denk, Helmut Zatloukal, Kurt Lehrach, Hans Wierling, Christoph PLoS One Research Article BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has a broad spectrum of disease states ranging from mild steatosis characterized by an abnormal retention of lipids within liver cells to steatohepatitis (NASH) showing fat accumulation, inflammation, ballooning and degradation of hepatocytes, and fibrosis. Ultimately, steatohepatitis can result in liver cirrhosis and hepatocellular carcinoma. METHODOLOGY AND RESULTS: In this study we have analyzed three different mouse strains, A/J, C57BL/6J, and PWD/PhJ, that show different degrees of steatohepatitis when administered a 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) containing diet. RNA-Seq gene expression analysis, protein analysis and metabolic profiling were applied to identify differentially expressed genes/proteins and perturbed metabolite levels of mouse liver samples upon DDC-treatment. Pathway analysis revealed alteration of arachidonic acid (AA) and S-adenosylmethionine (SAMe) metabolism upon other pathways. To understand metabolic changes of arachidonic acid metabolism in the light of disease expression profiles a kinetic model of this pathway was developed and optimized according to metabolite levels. Subsequently, the model was used to study in silico effects of potential drug targets for steatohepatitis. CONCLUSIONS: We identified AA/eicosanoid metabolism as highly perturbed in DDC-induced mice using a combination of an experimental and in silico approach. Our analysis of the AA/eicosanoid metabolic pathway suggests that 5-hydroxyeicosatetraenoic acid (5-HETE), 15-hydroxyeicosatetraenoic acid (15-HETE) and prostaglandin D2 (PGD2) are perturbed in DDC mice. We further demonstrate that a dynamic model can be used for qualitative prediction of metabolic changes based on transcriptomics data in a disease-related context. Furthermore, SAMe metabolism was identified as being perturbed due to DDC treatment. Several genes as well as some metabolites of this module show differences between A/J and C57BL/6J on the one hand and PWD/PhJ on the other. Public Library of Science 2014-10-27 /pmc/articles/PMC4210132/ /pubmed/25347188 http://dx.doi.org/10.1371/journal.pone.0111006 Text en © 2014 Pandey et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Pandey, Vikash Sultan, Marc Kashofer, Karl Ralser, Meryem Amstislavskiy, Vyacheslav Starmann, Julia Osprian, Ingrid Grimm, Christina Hache, Hendrik Yaspo, Marie-Laure Sültmann, Holger Trauner, Michael Denk, Helmut Zatloukal, Kurt Lehrach, Hans Wierling, Christoph Comparative Analysis and Modeling of the Severity of Steatohepatitis in DDC-Treated Mouse Strains |
title | Comparative Analysis and Modeling of the Severity of Steatohepatitis in DDC-Treated Mouse Strains |
title_full | Comparative Analysis and Modeling of the Severity of Steatohepatitis in DDC-Treated Mouse Strains |
title_fullStr | Comparative Analysis and Modeling of the Severity of Steatohepatitis in DDC-Treated Mouse Strains |
title_full_unstemmed | Comparative Analysis and Modeling of the Severity of Steatohepatitis in DDC-Treated Mouse Strains |
title_short | Comparative Analysis and Modeling of the Severity of Steatohepatitis in DDC-Treated Mouse Strains |
title_sort | comparative analysis and modeling of the severity of steatohepatitis in ddc-treated mouse strains |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210132/ https://www.ncbi.nlm.nih.gov/pubmed/25347188 http://dx.doi.org/10.1371/journal.pone.0111006 |
work_keys_str_mv | AT pandeyvikash comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT sultanmarc comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT kashoferkarl comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT ralsermeryem comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT amstislavskiyvyacheslav comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT starmannjulia comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT osprianingrid comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT grimmchristina comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT hachehendrik comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT yaspomarielaure comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT sultmannholger comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT traunermichael comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT denkhelmut comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT zatloukalkurt comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT lehrachhans comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains AT wierlingchristoph comparativeanalysisandmodelingoftheseverityofsteatohepatitisinddctreatedmousestrains |